Related Experiment Videos
Integrated magnetic resonance and 31p spectroscopy.
Transactions - Pennsylvania Academy of Ophthalmology and Otolaryngology
|January 1, 1989
Summary
Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) integrate to assess head and neck tumors. This combined approach noninvasively monitors tumor metabolites, aiding in therapy response evaluation.
Area of Science:
- Oncology
- Radiology
- Biochemistry
Background:
- Magnetic resonance imaging (MRI) is crucial for evaluating head and neck neoplasms.
- Integrating magnetic resonance spectroscopy (MRS) with MRI allows for localized metabolic analysis.
Purpose of the Study:
- To discuss the integration of MRI and MRS for head and neck tumors.
- To present examples of integrated MRI/MRS data for various lesions.
- To review the potential of this technique in monitoring therapeutic response.
Main Methods:
- Utilizing MRI for precise anatomical assessment of tumors.
- Employing multinuclear magnetic resonance spectra (1H and 31P) for localized metabolite measurement.
- Integrating spectroscopy into clinical MRI examinations.
Main Results:
- Demonstrated ability to localize specific volumes of interest within tumors.
- Provided examples of integrated MRI/MRS data from head and neck lesions.
- Highlighted the noninvasive monitoring of mobile metabolite concentrations.
Conclusions:
- Integrated MRI/MRS offers a noninvasive method for assessing head and neck neoplasms.
- The technique enables monitoring of relative metabolite concentrations within tumors.
- This approach shows potential for evaluating tumor response to therapy.